HMMR potential as a diagnostic and prognostic biomarker of cancer—speculation based on a pan-cancer analysis
BackgroundAlthough the status of universal upregulation for the Hyaluronan-Mediated Motility Receptor (HMMR) in pan-cancer is still unknown, HMMR is upregulated and associated with poor prognosis for some tumors.MethodsExploring HMMR expression in different tumor types using The Cancer Genome Atlas...
Main Authors: | Junyi Shang, Xiaoju Zhang, Guangjie Hou, Yong Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2022.998598/full |
Similar Items
-
Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma via integrated bioinformatics analysis
by: Zhaodong Li, et al.
Published: (2021-12-01) -
HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas
by: Huaxin Zhu, et al.
Published: (2023-02-01) -
Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis
by: Qin Qin, et al.
Published: (2023-11-01) -
HMMR promotes peritoneal implantation of gastric cancer by increasing cell–cell interactions
by: Muwen Yang, et al.
Published: (2022-08-01) -
A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
by: Dinglong Yang, et al.
Published: (2022-07-01)